Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
COVID-19 P&C Industry Update: Regulations, Telemedicine, Access to Care and Testing
Mitchell
News Release
Accelerating the Shift to Virtual Claims
Workers' Comp
Blog
Impact of Masks on the Deaf Community
While everyone has been affected by the COVID-19 pandemic in one way or another, the deafblind community has been affected in a detrimental way tha
Mitchell
News Release
CEO Alex Sun Introduces Mitchell’s 2nd Quarter 2020 Industry Trends Report
SAN DIEGO, CA—Mitchell International, a leading provider of technology, connectivity and information solutions to the property & casualty claim
Workers' Comp
Virtual Event
Webinar: Five Tips to Prevent Remote Employee Injuries
On-Demand
Working from home shouldn't be painful,
Workers' Comp
Blog
Opioid Trends Continue to Decline in 2019
First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a